跳至主要内容
临床试验/EUCTR2005-003211-69-AT
EUCTR2005-003211-69-AT进行中(未招募)不适用

Anticoagulation with Prostaglandin E1 and unfractioned Heparin versus Placebo and unfractioned Heparin during continuous venovenous hemofiltration

Medical University of Vienna0 个研究点开始时间: 2005年8月16日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Female and male intensive care patients aged 18-80 years
  • Diagnosis of acute renal failure
  • Treatment with continuous venovenous hemofilartion therapy
  • Adequate contraception in women withh ildbearing potential
  • signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Pregnant and nursing women
  • known incompatibility against substances used in this trial
  • pre-existing clotting or platelet disorder
  • Concomitant therapy with Aspirin within two weeks before study start or during the study
  • Concomitant tretament with nonsteroidal anti-inflammatory drugs (NSAIDs) within two weeks before the study start or during the study
  • Concomitant therapy with Marcoumar within two weeks before study start or during the study
  • Concomitant therapy with other extracorporeal replacement therapies
  • Patients simultaneously participating, or having participated in the last month, in another clinical trial
  • Patients taken in custody by court or authorities
  • Patients already treated under this protocol

研究者

相似试验